Cancer Research Technology
Log in Register
Menu

anti- HIV-1 protease iBody small molecule (tool compound)

Invented by Jan Tykvart , at Institute of Organic Chemistry and Biochemistry, Institute of Macromolecular Chemistry, Charles University Frantisek Sedlak , at Institute of Organic Chemistry and Biochemistry, Institute of Macromolecular Chemistry, Charles University Pavel Majer, at Institute of Organic Chemistry and Biochemistry, Institute of Macromolecular Chemistry, Charles University Petr Cigler , at Institute of Organic Chemistry and Biochemistry, Institute of Macromolecular Chemistry, Charles University Vaclav Navratil, at Institute of Organic Chemistry and Biochemistry, Institute of Macromolecular Chemistry, Charles University Vladimir Subr , at Institute of Organic Chemistry and Biochemistry, Institute of Macromolecular Chemistry, Charles University Karel Ulbich, at Institute of Organic Chemistry and Biochemistry, Institute of Macromolecular Chemistry, Charles University Jiri Strohalm, at Institute of Organic Chemistry and Biochemistry, Institute of Macromolecular Chemistry, Charles University Jan Konvalinka , at Institute of Organic Chemistry and Biochemistry, Institute of Macromolecular Chemistry, Charles University Jiří Schimer, at Institute of Organic Chemistry and Biochemistry, Institute of Macromolecular Chemistry, Charles University Tomas Knedlik , at Institute of Organic Chemistry and Biochemistry, Institute of Macromolecular Chemistry, Charles University Sacha Pavel at Institute of Organic Chemistry and Biochemistry, Institute of Macromolecular Chemistry, Charles University

Info

Catalogue Number 157995
Antigen/Gene or Protein Targets Targeting HIV-1 protease using HIV1 PR specific inhibitor
Synonyms HIV-1 PR; HIV-1 protease; HIV-2 protease; HIV1 PR; HIV2 PR; HIV1 protease
Relevance HIV-1 protease is a retroviral aspartyl protease (retropepsin), an enzyme involved with peptide bond hydrolysis in retroviruses, that is essential for the life-cycle of HIV, the retrovirus that causes AIDS.

- iBodies® are capable of replacing antibodies in biomedical applications such as ELISA, flow cytometry, confocal microscopy, immunocytochemistry, Western Blot and immunoprecipitation.
- These iBodies® consist of an N-(2-hydroxypropyl)methacrylamide (HPMA) copolymer decorated with low-molecular-weight compounds that function as targeting ligand (e.g., enzyme inhibitors, receptor ligands), affinity anchor (e.g., biotin) and/or imaging probe (various fluorophores).
- These iBodies® have been used for enzyme inhibition, protein isolation, immobilization, quantification and live cell imaging as well as for classical Western Blot application. The system is remarkably modular and can be used for different biological/biochemistry assays.
Research Area Cell Cycle, Cell Signaling & Signal Transduction, Immunology, Virology
Notes iBodies(R) is a registered trade mark of IOCB Tech s.r.o.

References

There are 3 reference entries for this reagent.

View All References

References: 3 entries

Šimon et al. 2018. ACS Chem Biol. 13(12):3333-3342. PMID: 30489064.

Dvořáková et al. 2017. J Med Chem. 60(20):8385-8393. PMID: 28953383.

Šácha et al. 2016. Angew Chem Int Ed Engl. 55(7):2356-60. PMID: 26749427.


Add a reference

References: 3 entries

Šimon et al. 2018. ACS Chem Biol. 13(12):3333-3342. PMID: 30489064.

Dvořáková et al. 2017. J Med Chem. 60(20):8385-8393. PMID: 28953383.

Šácha et al. 2016. Angew Chem Int Ed Engl. 55(7):2356-60. PMID: 26749427.


Add a reference

Inventor Information

Inventors

Jan Tykvart

Jan Tykvart

Frantisek Sedlak

Frantisek Sedlak

Pavel Majer

Pavel Majer

Petr Cigler

Petr Cigler

Vaclav Navratil

Vaclav Navratil

Vladimir Subr

Vladimir Subr

Karel Ulbich

Karel Ulbich

Jiri Strohalm

Jiri Strohalm

Jan Konvalinka

Jan Konvalinka

Jiří  Schimer

Jiří Schimer

Tomas Knedlik

Tomas Knedlik

Sacha  Pavel

Sacha Pavel

Add an inventor